# Therapy for Pediatric Hodgkin Lymphoma

> **NCT00145600** · PHASE2 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 296 (actual)

## Conditions studied

- Hodgkin Lymphoma

## Interventions

- **DRUG:** 12 Week Stanford V Chemotherapy
- **DRUG:** 4 cycles of VAMP chemotherapy
- **DRUG:** 2 alternating cycles of VAMP/COP chemotherapy
- **DRUG:** 3 alternating cycles of VAMP/COP chemotherapy

## Key facts

- **NCT ID:** NCT00145600
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03-02
- **Primary completion:** 2012-05-31
- **Final completion:** 2021-11-05
- **Target enrollment:** 296 (ACTUAL)
- **Last updated:** 2022-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145600, "Therapy for Pediatric Hodgkin Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00145600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*